info icon

This is a non-core endpoint: only basic statistics are computed.

Transepidermal elimination disorders

L12_TRANSEPIDERMELIMINATION

skin disease: Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.

Endpoint definition

↥
FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 L87
Cause of death: ICD-10 L87

2 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

42

diagram downward connector
L12_TRANSEPIDERMELIMINATION

Control definitions

Control exclude L12_OTHERSKINSUBCUTIS

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 L80-L99
Name in latin Perturbationes eliminationis transepidermalis

Similar endpoints

↥

List of similar endpoints to Transepidermal elimination disorders based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 42 27 15
Unadjusted prevalence (%) 0.01 0.01 0.01
Mean age at first event (years) 52.63 51.76 54.18

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

↥

Index endpoint: L12_TRANSEPIDERMELIMINATION – Transepidermal elimination disorders
GWS hits:

Survival analyses between endpoints

↥

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Transepidermal elimination disorders

↥

Endpoint not on priority list, no data to show.